Cascade Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Cascade Investment Advisors's AMGN Position: Q2 2023 in Review
Cascade Investment Advisors sold out of Amgen (AMGN) in Q2 2023, closing a stake of 6,948 shares — an estimated $1.68M sold.
Cascade Investment Advisors first reported a position in AMGN in Q2 2016 and held it in 27 quarters. The position peaked at $2.21M in Q1 2022. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.
- Cascade Investment Advisors reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
- Cascade Investment Advisors sold 6,948 Amgen shares in Q2 2023, an estimated $1.68M.
- Cascade Investment Advisors first reported a position in Amgen in Q2 2016 and held it in 27 quarters.
- Cascade Investment Advisors's Amgen position peaked at $2.21M in Q1 2022.
- 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.
Based on Cascade Investment Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.